Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA/ FR0013154002 /
DIM
2024-09-26 5:35:28 PM
|
Chg.
+13.60
|
Volume |
Bid5:40:00 PM |
Ask5:40:00 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
183.95EUR
|
+7.98%
|
118,794 Turnover: 20.03 mill. |
179.00Bid Size: 110 |
185.00Ask Size: 233 |
16.96 bill.EUR |
0.38% |
54.75 |
Fundamentals
|
FY 2023 |
Growth (1Y) |
Per Share |
|
Earnings per Share: |
3.36 EUR |
-64.67% |
EPS Diluted: |
- EUR |
-64.67% |
Revenues per Share: |
30.11 EUR |
-20.53% |
Book Value per Share: |
28.62 EUR |
7.70% |
Cash Flow per Share: |
8.10 EUR |
21.90% |
Dividend per Share: |
0.69 EUR |
-52.08% |
Total |
in mill. |
|
Revenues: |
2,775.50 EUR |
-20.53% |
Net Income: |
309.70 EUR |
-64.65% |
Operating Cash Flow: |
746.40 EUR |
- |
Cash and Cash Equivalents: |
116.60 EUR |
- |
Valuation Ratios
|
Current |
Latest FY* |
P/E Ratio: |
54.75 |
71.28 |
P/S Ratio: |
6.11 |
7.95 |
P/BV ratio: |
6.43 |
8.37 |
P/CF Ratio: |
22.72 |
29.58 |
PEG: |
-0.85 |
-1.10 |
Earnings Yield: |
1.83% |
1.40% |
Dividend Yield: |
0.38% |
0.29% |
Market Capitalization |
|
Market Capitalization: |
16.96 bill. EUR |
22.08 bill. EUR |
Free Float Market Cap.: |
- EUR |
- EUR |
Market Cap. / Employee: |
1.59 mill. EUR |
2.07 mill. EUR |
Shares Outstanding: |
92.18 mill. |
|
Profitability
Gross Profit Margin: |
44.44% |
EBIT Margin: |
16.17% |
Net Profit Margin: |
11.16% |
Return on Equity: |
11.74% |
Return on Assets: |
4.00% |
Financial Strength
Liquidity I / Cash Ratio: |
12.44% |
Liquidity II / Quick Ratio: |
43.77% |
Liquidity III / Current Ratio: |
150.98% |
Debt / Equity Ratio: |
193.41% |
Dynam. Debt / Equity Ratio: |
683.55% |
Efficiency
Employees: |
10,662 |
Personal Expenses / Employee: |
- EUR |
Revenues / Employee: |
260,317.01 EUR |
Net Income / Employee: |
29,047.08 EUR |
Total Assets / Employee: |
725,933.22 EUR |
* Fiscal Year End: |
2023-12-31 |
Accounting Standard: |
IFRS |